Kristian Reich
Oprichter bij MOONLAKE IMMUNOTHERAPEUTICS
Vermogen: 134 M $ op 30-04-2024
Actieve functies van Kristian Reich
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
MOONLAKE IMMUNOTHERAPEUTICS | Hoofd Techniek/Wetenschap/O&O | 05-04-2022 | - |
Oprichter | 05-04-2022 | - | |
Moonlake Immunotherapeutics AG
Moonlake Immunotherapeutics AG Pharmaceuticals: MajorHealth Technology Part of MoonLake Immunotherapeutics, Moonlake Immunotherapeutics AG is a Swiss clinical-stage biopharmaceutical company. The company is based in Zug, Switzerland. The company was founded in 2021 by Jorge Santos da Silva, Arnout Ploos van Amstel, and Kristian Reich. Jorge Santos da Silva has been the CEO since 2021. Moonlake Immunotherapeutics was acquired by Helix Acquisition Corp. on April 05, 2022 for $395.41 million. | Hoofd Techniek/Wetenschap/O&O | 01-05-2021 | - |
Oprichter | 01-05-2021 | - | |
JeruCON Beratungsgesellschaft mbH | Hoofd Techniek/Wetenschap/O&O | - | - |
Oprichter | - | - | |
derma2go AG
derma2go AG Internet Software/ServicesTechnology Services Derma2go AG operates an online platform for dermatological consultation. The company is based in Zurich, Switzerland. The Swiss company was founded in 2018 by Christian Greis and Vahid Djamei. Christian Greis has been the CEO since 2018. | Directeur/Bestuurslid | - | - |
Dermagnostix GmbH | Directeur/Bestuurslid | - | - |
Proderma Foundation | Directeur/Bestuurslid | - | - |
Loopbaan van Kristian Reich
Eerdere bekende functies van Kristian Reich
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Dermatologikum Hamburg GmbH
Dermatologikum Hamburg GmbH Medical/Nursing ServicesHealth Services Dermatologikum Hamburg GmbH operates dermatologist clinics. Its services include prevention and skin checks, phototherapy, general dermatology, acne and rosacea, hair and scalp disorders, skin cancer and dermatological oncology, psoriasis, neurodermatitis and vascular & venous disease treatment. The company was founded by Volker Steinkraus in September 1997 and is headquartered in Hamburg, Germany. | Corporate Officer/Principal | 01-01-2005 | 01-01-2015 |
University of Gottingen | Corporate Officer/Principal | 01-01-1996 | - |
Opleiding van Kristian Reich
University of Freiburg | Undergraduate Degree |
Technische Universität München | Doctorate Degree |
University of Gottingen | Doctorate Degree |
Statistieken
Internationaal
Duitsland | 8 |
Zwitserland | 4 |
Operationeel
Chief Tech/Sci/R&D Officer | 3 |
Founder | 3 |
Doctorate Degree | 3 |
Sectoraal
Consumer Services | 4 |
Health Technology | 3 |
Health Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
MOONLAKE IMMUNOTHERAPEUTICS | Health Technology |
Bedrijven in privébezit | 6 |
---|---|
Dermatologikum Hamburg GmbH
Dermatologikum Hamburg GmbH Medical/Nursing ServicesHealth Services Dermatologikum Hamburg GmbH operates dermatologist clinics. Its services include prevention and skin checks, phototherapy, general dermatology, acne and rosacea, hair and scalp disorders, skin cancer and dermatological oncology, psoriasis, neurodermatitis and vascular & venous disease treatment. The company was founded by Volker Steinkraus in September 1997 and is headquartered in Hamburg, Germany. | Health Services |
derma2go AG
derma2go AG Internet Software/ServicesTechnology Services Derma2go AG operates an online platform for dermatological consultation. The company is based in Zurich, Switzerland. The Swiss company was founded in 2018 by Christian Greis and Vahid Djamei. Christian Greis has been the CEO since 2018. | Technology Services |
Moonlake Immunotherapeutics AG
Moonlake Immunotherapeutics AG Pharmaceuticals: MajorHealth Technology Part of MoonLake Immunotherapeutics, Moonlake Immunotherapeutics AG is a Swiss clinical-stage biopharmaceutical company. The company is based in Zug, Switzerland. The company was founded in 2021 by Jorge Santos da Silva, Arnout Ploos van Amstel, and Kristian Reich. Jorge Santos da Silva has been the CEO since 2021. Moonlake Immunotherapeutics was acquired by Helix Acquisition Corp. on April 05, 2022 for $395.41 million. | Health Technology |
JeruCON Beratungsgesellschaft mbH | |
Dermagnostix GmbH | |
Proderma Foundation |
- Beurs
- Insiders
- Kristian Reich
- Ervaring